Agios (AGIO) Up 5% on Upbeat Data From Thalassemia Study
https://www.zacks.com/stock/news/2205766/agios-agio-up-5-on-upbeat-data-from-thalassemia-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2205766
Jan 04, 2024 - Data from a late-stage study shows that non-transfusion-dependent thalassemia patients who received Agios' (AGIO) mitapivat demonstrated a statistically significant increase in hemoglobin response.
0
T-Mobile (TMUS), SpaceX Team Up for Direct-to-Cell Services
https://www.zacks.com/stock/news/2205750/t-mobile-tmus-spacex-team-up-for-direct-to-cell-services?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2205750
Jan 04, 2024 - T-Mobile (TMUS) collaborates with SpaceX to extend its coverage in remote locations, leveraging the latter's Direct to Cell technology.
0
Biotech Stock Roundup: VYGR Gains From NVS Deal, AGIO Up on Study Data & More
https://www.zacks.com/stock/news/2205605/biotech-stock-roundup-vygr-gains-from-nvs-deal-agio-up-on-study-data-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-2205605
Jan 04, 2024 - Collaboration news from Voyager (VYGR) and study updates from Agios (AGIO) are the key highlights this week.
0
Sizing up how the end of 2023 was for restaurants
https://www.nrn.com/first-bite/sizing-how-end-2023-was-restaurants
Jan 04, 2024 - Consumers said they were going to dine out during the holidays, and recently released data indicates they did just that.
A National Restaurant Association survey from early December showed that 63% of adults planned to eat out during the s
0
Allstate (ALL) Up 29% in 6 Months: What's Ahead for Investors?
https://www.zacks.com/stock/news/2205237/allstate-all-up-29-in-6-months-what-s-ahead-for-investors?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2205237
Jan 03, 2024 - Allstate (ALL) remains well-poised for growth on improved P&C insurance premiums, acquisitions and sufficient cash-generating abilities.
0
Dry January may help improve your finances. One woman has already saved $48,000 by giving up alcohol
https://www.cnbc.com/2024/01/03/how-dry-january-can-help-you-save-money-improve-health.html
Jan 03, 2024 - If you're on the fence about partaking in Dry January, there's an incentive to consider: the financial savings.
0
Piper Sandler raises Teva to neutral, stock up 4%
https://seekingalpha.com/news/4052045-piper-sandler-raises-teva-to-neutral-stock-climbs?source=feed_sector_healthcare
Jan 03, 2024 - Piper Sandler has upgraded Teva (TEVA) to neutral, citing the company’s efforts to lower its debt and “lean into its brand assets." The investment bank added, h
0
Limbach (LMB) Is Up 1.84% in One Week: What You Should Know
https://www.zacks.com/stock/news/2205162/limbach-lmb-is-up-1-84-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2205162
Jan 03, 2024 - Does Limbach (LMB) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Longboard Pharma (LBPH) Up on Upbeat Data From Epilepsy Study
https://www.zacks.com/stock/news/2204966/longboard-pharma-lbph-up-on-upbeat-data-from-epilepsy-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2204966
Jan 03, 2024 - Longboard Pharma (LBPH) skyrockets 316% on positive data from phase Ib/IIa study of bexicaserin for the treatment of seizures associated with a broad range of epilepsy indications.
0
Daktronics: Fast Growth, But The Order Backlog Is Drying Up
https://seekingalpha.com/article/4660847-daktronics-fast-growth-but-the-order-backlog-is-drying-up?source=feed_all_articles
Jan 02, 2024 - Daktronics' revenues and net income have been growing rapidly since FY22 and the forecasts for global LED video display market are bright. Read more on DAKT here.
0